PBAC Public Summary Documents - July 2010

Public summary documents relating to the July 2010 PBAC meeting

• ALENDRONATE SODIUM, tablet equivalent to 70 mg alendronic acid, Fosamax Once Weekly^®, ALENDRONATE SODIUM with COLECALCIFEROL tablet equivalent to 70 mg alendronic acid with 70 micrograms colecalciferol, Fosamax Plus^®, ALENDRONATE SODIUM with COLECALCIFEROL tablet equivalent to 70 mg alendronic acid with 140 micrograms colecalciferol, Fosamax Plus 70 mg/140 mcg^®, ALENDRONATE SODIUM with COLECALCIFEROL and CALCIUM CARBONATE, pack containing 4 tablets containing the equivalent of 70 mg alendronic acid with 140 micrograms colecalciferol and 48 tablets calcium carbonate 1.25 g (equivalent to 500 mg calcium), Fosamax Plus D-Cal®, July 2010
• ALISKIREN, tablets, 150 mg and 300 mg (as hemifumarate), Rasilez®, July 2010
• AMLODIPINE (as besylate) with VALSARTAN and HYDROCHLOROTHIAZIDE, tablets, 5 mg-160 mg-12.5 mg, 5 mg-160 mg-25 mg, 10 mg-160 mg-12.5 mg, 10 mg-160 mg-25 mg, and 10 mg-320 mg-25 mg, Exforge HCT^®, July 2010
• CETUXIMAB, solution for I.V. infusion, 100 mg in 20 mL and 500 mg in 100 mL, Erbitux^®, July 2010
• CILOSTAZOL, tablets, 50 mg and 100 mg, Pletal^®, July 2010
• DARUNAVIR, tablet, 400 mg (as ethanolate), Prezista®, July 2010
• DEGARELIX, powder for subcutaneous injection (modified release), 80 mg and 120 mg, (as acetate) with solvent, syringe and needles, Firmagon^®, July 2010
• DENOSUMAB, injection, 60 mg in 1 mL, single use pre-filled syringe, Prolia^® , July 2010
• ECULIZUMAB, solution concentrate for I.V. infusion, 300 mg in 30 mL, Soliris®, July 2010
• EPOETIN LAMBDA, injection, 1,000 units in 0.5 mL, 2,000 units in 1.0 mL, 3,000 units in 0.3 mL, 4,000 units in 0.4 mL, 5,000 units in 0.5 mL, 6,000 units in 0.6 mL, 8,000 units in 0.8 mL and 10,000 units in 1.0 mL, pre-filled syringe, Novicrit^® , July 2010
• EVEROLIMUS, tablets, 5 mg and 10 mg, Afinitor^®, July 2010
• ICATIBANT, injection, 30 mg in 3 mL (as acetate), single use pre-filled syringe, Firazyr®, July 2010
• IMATINIB, tablets, 100 mg and 400 mg (as mesylate), Glivec®, July 2010
• LOSARTAN, tablets, 25 mg and 50 mg (as potassium), Cozavan^®, July 2010
• MIGLUSTAT, capsule, 100 mg, Zavesca®, July 2010
• OLMESARTAN MEDOXOMIL with AMLODIPINE (as besylate), tablets, 20 mg-5 mg, 20 mg-10 mg, 40 mg-5 mg and 40 mg-10 mg, Sevikar^®, July 2010
• OXYCODONE HYDROCHLORIDE and NALOXONE HYDROCHLORIDE DIHYDRATE, tablets, 5 mg-2.5 mg, 10 mg-5 mg, 20 mg-10 mg and 40 mg-20 mg (controlled release), Targin®, July 2010
• PAZOPANIB, tablets, 200 mg and 400 mg (as hydrochloride), Votrient®, July 2010
• PNEUMOCOCCAL POLYSACCHARIDE CONJUGATE VACCINE, 13-valent adsorbed, injection, 0.5 mL, pre-filled syringe, Prevenar-13^®, July 2010
• QUETIAPINE, tablets, 25 mg, 100 mg, 200 mg and 300 mg (as fumarate), Seroquel^®, and tablets (modified release), 50 mg, 200 mg, 300 mg and 400 mg (as fumarate), Seroquel XR^®, July 2010
• RIBAVIRIN, tablets, 200 mg, (112 tablets, 140 tablets and 168 tablets) and PEGINTERFERON ALFA-2a, pre-filled syringes, 180 micrograms and RIBAVIRIN, tablets, 200 mg, (168 tablets) and PEGINTERFERON ALFA-2a, pre-filled syringes 135 micrograms, Pegasys RBV^®, July 2010
• RISEDRONATE SODIUM, tablet, 5 mg, Actonel^®, 35 mg, Actonel Once-a-Week^® and 150 mg, Actonel Once-a-Month^®, RISEDRONATE SODIUM and CALCIUM CARBONATE, pack containing 4 tablets risedronate sodium 35 mg and 24 tablets calcium carbonate 1.25 g (equivalent to 500 mg calcium), Actonel Combi^®, RISEDRONATE SODIUM and CALCIUM CARBONATE with COLECALCIFEROL, pack containing 4 tablets risedronate sodium 35 mg and 24 sachets containing granules of calcium carbonate 2.5 g (equivalent to 1 g calcium) with colecalciferol 22 micrograms, Actonel Combi D^®, July 2010
• ROMIPLOSTIM, powder for injection, 100 micrograms, 250 micrograms and 500 micrograms, Nplate®, July 2010
• SOLIFENACIN, tablet, 5 mg and 10 mg (as succinate), Vesicare^®, July 2010
• TOPOTECAN,capsules, 0.25 mg and 1 mg (as hydrochloride), Hycamtin®, July 2010